YD Bio announces newly planned California facilities, operations center

YD Bio (YDES)announced initiation of its latest plans for new facilities and a U.S. operations center in California to accelerate clinical development, regulatory engagement and commercial access for next-generation diagnostics and exosome-based therapeutics. The California operations center is currently in the site evaluation phase and the specific host city has not yet been finalized. It will support clinical collaboration, regulatory strategy and scaled operational capabilities, which is intended to assist with enabling faster clinical validation, more efficient regulatory submissions and improved access to non-invasive cancer tests and advanced diagnostic services across the United States.